Stay updated with breaking news from Bio Path Daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Bio-Path Holdings, Inc. (NASDAQ:BPTH – Get Free Report) was the target of a significant drop in short interest in May. As of May 15th, there was short interest totalling 24,000 shares, a drop of 45.9% from the April 30th total of 44,400 shares. Currently, 1.5% of the company’s stock are short sold. Based on an […]
Bio-Path Holdings, Inc. (NASDAQ:BPTH – Free Report) – Research analysts at Roth Capital upped their Q2 2024 earnings per share estimates for shares of Bio-Path in a research note issued to investors on Wednesday, May 15th. Roth Capital analyst J. Aschoff now forecasts that the company will post earnings of ($2.06) per share for the […]
Bio-Path Holdings, Inc. (NASDAQ:BPTH – Free Report) – Roth Capital boosted their Q2 2024 earnings per share estimates for Bio-Path in a report released on Wednesday, May 15th. Roth Capital analyst J. Aschoff now forecasts that the company will post earnings per share of ($2.06) for the quarter, up from their previous estimate of ($4.60). […]
StockNews.com started coverage on shares of Bio-Path (NASDAQ:BPTH – Free Report) in a research note issued to investors on Thursday morning. The firm issued a sell rating on the stock. Separately, Roth Mkm reaffirmed a buy rating and set a $40.00 price target on shares of Bio-Path in a research report on Thursday, April 18th. […]
StockNews.com started coverage on shares of Bio-Path (NASDAQ:BPTH – Free Report) in a report published on Wednesday. The firm issued a sell rating on the stock. Separately, Roth Mkm reissued a buy rating and set a $40.00 price objective on shares of Bio-Path in a research report on Thursday, April 18th. Get Our Latest Research […]